Core Viewpoint - The article highlights the development and significance of the biopharmaceutical industry in Qiantang District, Hangzhou, emphasizing its role as a key area for high-quality growth in the sector [1][2]. Group 1: Industry Development - The biopharmaceutical industry in Qiantang District is positioned as a flagship for Hangzhou's ambition to become a globally influential biopharmaceutical innovation city [1]. - Hangzhou Pharmaceutical Port is identified as the only core area of the city's biopharmaceutical "one core, four parks, multiple points" strategy, housing over 1,733 biopharmaceutical-related enterprises and employing approximately 35,000 workers [1]. - The port covers an area of about 4.92 square kilometers and includes 21 micro-parks, showcasing a robust industrial ecosystem [1]. Group 2: Research and Initiatives - A joint research team from the Hangzhou Municipal Committee and the Hangzhou Two New Party Workers Association conducted a study on the party-building work within the biopharmaceutical industry chain [1][2]. - The research focused on the "chain + cluster" development model adopted by Hangzhou Pharmaceutical Port, which integrates six chains: innovation, industry, talent, policy, finance, and service [1]. - The study also explored the Party-Mass Service Center at the pharmaceutical port, recognized as a provincial model, which aims to enhance organizational leadership and activate talent through a cohesive ecosystem [2]. Group 3: Community and Talent Engagement - The pharmaceutical port's community includes 12 dedicated social workers, providing services to the core area and fostering a supportive environment for employees [1]. - The research team observed various facilities aimed at employee engagement, such as gyms and reading stations, which extend services beyond working hours to create a sticky ecosystem for talent [2]. - The initiative aims to transform localized experiences into broader mechanisms, leveraging party organization advantages for regional development [2].
“链”上发力 壮大生物医药生命力
Mei Ri Shang Bao·2025-06-05 22:14